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Chapter 1 
Introduction 
Development in mammals requires a complex array of regulatory signals and responses. 
It involves interdependent positive and negative regulation that leads to establishment of cell 
specialization via lineage dependent patterns of transcription. Trans-acting factors interacting 
with cis-acting elements within the DNA sequences play a key role in developmental regulation 
of tissue specific gene expression (Simone et al, 1987, Li et al, 1988). Genetic processes 
responsible for specification, establishment and maintenance of tissue identity have been 
extensively studied. However, the underlying mechanisms of tissue differentiation are still 
enigmatic and elusive. 
The mammalian hepatocyte has proven to be a useful model system in which to study 
cellular differentiation. Large numbers of liver enriched genes have been well characterized. 
These genes tend to be controlled by common regulatory pathways, which include several 
characterized master regulators. The hierarchal pathways for transcriptional activation involve 
both the repression and activation of various liver specific genes (Gourdeau & Fournier, 1990). 
1.1. Liver Development 
The mammalian liver is one of the largest essential organs (glands) of the human 
digestive system and exhibits endocrine and exocrine functions. It performs a number of 
complex and vital activities such as detoxification, metabolism (Tao & Peng, 2009), glycogen 
storage, secretion of digestive fluids, maintenance of homeostasis (Li et al 2010), regulation of 
cholesterol synthesis and transport, metabolism of urea and secretion of plasma proteins such as 
apo-lipoproteins and albumin. Since it is essential for life, its function cannot be replaced and/or 
compensated for with current technology. Therefore, liver diseases such as hepatic fibrosis, 
cirrhosis, hepatitis and hepatocellular carcinoma (HCC) have a high mortality rate (Si-Tayeb et 
al, 2010). The liver is composed of various differentiated cell types forming the organ: 
hepatocytes, cholangiocytes (bile duct epithelial cells), Kupffer cells (liver resident 
macrophages), hepatic stellate cells, and sinusoidal endothelium and pit cells (natural killer cells 
(Cheng et al, 2006). Each cell type has specific functions during proliferation and regeneration of 
the liver after hepatectomy and injury. 
Liver development ils a complex process with multiple stages. A vast numbers of genes 
are expressed by the liver in response to metabolic and catabolic needs of the body, with genes 
expressing products ranging from enzymes to hematopiotic components (Cheng et al, 2006). 
These expressed genes include both liver enriched transcription factors (TFs) and downstream 
genes (Cheng et al, 2006). Expression of albumin, transthyretin and a-fetoprotein are commonly 
used as markers for liver identity (Lemeigre, 2009). However, it is expression of TFs that is 
known to drive the liver phenotype. For example, transcription factors forkhead box protein A 
(FoxA) and GATA4 bind to the promoter of the albumin gene, opening the chromatin to allow 
binding of Hepatocyte Nuclear Factor la (HNFla) and CCAAT-enhancer binding protein B 
(C/EBPB) leading to transcription of the albumin gene (Lemeigre, 2009). During early 
embryonic development, FoxAl and FoxA2 genes are regulated by the hepatocyte nuclear 
factor-IB (HNFIB), and deficiencies in Fox A and/or HNFIB lead to impaired hepatic 
specification due to lack of competence by endoderm cells (Lemeigre, 2009). 
Liver ontology begins on embryonic day 9 (E9) in the mouse and requires interaction of 
intercellular and matrix-cellular proteins whose expression is influenced by hormonal factors 
(Ober et al, 2003). Tissue recombination experiments have shown that the cardiogenic mesoderm 
2 
et 
et migration, 
a 
morphology, relying upon co-
stages have showed 
occurs life. It lS the 
a cross-
vivo DNA-protein 
complexity and numerous interactions of cis-acting 
and binding 
are for the 
gene regulation (Odom et 2004). 
of lS TFs. core 
Ip, 
nuclear 
of one cut et 
3 
et al, 2004; Lemeigre, 2009) and CCAA T enhancer binding protein (C/EBP) (Lemeigre, 2009). 
The liver specific core transcription factors are synergistically interdependent and act by 
occupying gene regulatory regions and cooperating with cofactors to stimulate transcription of 
common targets. All these TFs are considered essential for normal functioning of liver and 
pancreatic tissues (Odom et al, 2004). 
The hepatic phenotype is at least partially maintained by HNFla, promoting transcription 
of more than 222 different liver specific genes (Odom et al, 2004). HNFla binds to the genes 
responsible for normal biochemical functioning such as gluconeogenesis and other major 
pathways. It also regulates the transcriptional products required for normal hepatic functioning 
such as carbohydrate synthesis and storage, detoxification (synthesis of cytochrome P450 
monooxygenase) and synthesis of serum proteins (albumin, complements and coagulation 
factors) (Odom et al, 2004). HNFl~ is involved in transcriptional regulation or genes essential 
for bile acid sensing and fatty acid oxidation (Lemeigre, 2009). HNF3~iFoxA2 regulates nonnal 
hepatic function through other liver enriched HNF's due to its overlapping DNA binding 
properties (Lemeigre, 2009). Liver receptor homolog-1 (LRH-1) controls bile acid and 
cholesterol metabolism, due to its association with the nuclear hormone receptor family 
(Lemeigre, 2009). 
Hepatocyte nuclear factor 4a (HNF4a) is a widely studied transcription factor which was 
shown to bind to 1262 (12% of genes tested) genes in hepatocytes and 1047 (11 % of genes 
tested) of genes in pancreatic cells out of 13,000 genes in gene array (Hul3K array) (Odom et al, 
2004). It is widely expressed and is constitutively active in these tissues. Transcriptome analysis 
has revealed that the majority of HNF4al bound promoter sites in genes are also bound by the 
RNA polymerase II, suggesting that HNF4al is crucial for normal transcriptional regulation 
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(Odom et al, 2004). Defects in expression or functioning of HNF4al or HNFla lead to maturity 
onset diabetes of the young (MODY), suggesting that they are vital for glucose metabolism. 
HNF6 binds 227 genes in hepatocytes and 189 in pancreatic islets (Odom et al, 2004). Its 
transcriptional regulation involves the mediating of effects of growth hormone, inhibiting 
glucocorticoid activity, and stimulating expression of genes in the gluconeogenic, glycolytic, and 
bile acid synthesis pathways (Lemeigre, 2009). It acts as a feed forward loop switch and also 
required for hepatocyte proliferation (Odom et al, 2004). 
C/EBP is not a core member of the liver transcriptional network but it participates in the 
transcriptional activation of genes expressed in the differentiated hepatic cells and has been the 
first to attract the attention of hepatologists. C/EBP is a liver nuclear protein having affinity for 
CCAAT, a core enhancer element (Lemeigre, 2009). C/EBP family consists of C/EBPa and 
CIEBP~. CIEBPa regulates glucose and glycogen metabolism, lipid homeostasis and hepatocyte 
proliferation whereas C/EBP~ regulates gfoconeogenesis and stimulates phosphoenolpyruvate 
carboxykinase (PEPCK) (Lemeigre, 2009). 
The synergistic association between HNFla, HNF4al and HNF6 drives hepatic 
transcriptional regulation (Odom et al, 2004). These HNF's occupy the promoter of the genes 
encoding transcription factors and cofactors that cooperatively regulate developmental and 
metabolic functions in hepatocytes (Bulla et al, 2000). Transcriptional regulatory studies suggest 
that HNFla and HNF4al form a multicomponent loop (i.e. they occupy each other's promoters 
in hepatocytes) (Bulla et al, 2000). This loop helps to create a bistable system- with an ability to 
switch between two alternate states and establish a feedback control mechanism. Similarly, 
HNF6, HNFla and HNF4al form a multi-input motif suggesting regulation of gene expression 
through multiple inputs. These HNFs are responsible for maintaining the terminal phenotypes of 
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hepatocytes. Binding of these HNF's plays a vital role, to regulate the tissue specific expression 
of the downstream genes (Odom et al, 2004). 
Since transcriptional regulator controls the development, differentiation and homeostasis 
via tissue specific gene expression, unnecessary and conflicting genes are repressed 
simultaneously (Teitell & Mikkola, 2006). In some cases, repressors are generated via a 
mechanism of alternative splicing of a single gene. Repression of the transcriptional process is 
then executed by blocking the entry of RNA polymerase II from forming a pre-initiation 
complex by binding directly with transcription binding protein (TBP) (Aso et al, 1994). 
Transcription activators or co-activators target these negative co-factors by releasing them from 
the repressed pre-initiation complex and activating transcription. These negative co-factors act as 
a molecular switch (Aso et al, 1994). Thus, tissue specific gene expression requires the 
interaction between transcription activators and repressors and their complexes. 
1.2. Cell Culture Models Systems 
One technique utilized historically to study liver gene hierarchies is cell fusion (Gourdeau 
& Fournier, 1990). Cells of two distinct and highly differentiated cell types, such as hepatoma 
cells and fibroblast cells, can be fused to generate somatic cell hybrids. These hybrids fail to 
express liver specific genes, a process termed extinction. However, unlike tissue specific genes, 
housekeeping genes of both the parents continue to be expressed. Extinction of gene expression 
in somatic cell hybrids can sometimes be reversed when chromosomes from one of the parents 
are lost during cell division (usually the fibroblast chromosome are lost) (Gourdeu & Fournier, 
1990). 
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A second method used to understand mechanisms driving liver identity exploit the 
identification of mutant hepatocytes, specifically lacking expression of liver specific genes 
(Bulla & Fournier, 1994). These mutants are called variants because they presumably have 
multiple genetic or epigenetic lesions that lead to de-differentiation. Screening of these variants 
and studying their expression profile have helped to elucidate the effects of HNFs in hepatocytes, 
including their activation and transcriptional regulation of downstream genes (Bulla & Kruas, 
2004). Exploitation of these dedifferentiated variants to study the mechanism of HNFs have 
contributed to understanding the specific defects in regulatory pathways and serve as a tool for 
devising a role of each in maintaining the liver phenotype (Bulla et al, 1994). The rescue of the 
liver phenotype in hepatoma variant cells has contributed to our understanding of liver genetics. 
Hematoma variants were selected from rat hepatoma cells by means of both negative and 
positive selection strategies. They were further characterized based on their morphology and 
expression of liver specific genes (Bulla & Fournier, 1994). Importantly, expression of HNF4 
and HNFla genes is absent in variants (Bulla et al, 1999). Ectopic expressions of HNF4 and/or 
HNF 1 a rescue each other as well as downstream liver genes, suggesting that these cells are 
suitable for studying the hierarchical pathways in transcriptional regulation (Bulla & Fournier, 
1994). 
Studies conducted in the current project are based upon dedifferentiated cells generated 
from the original rat tumor cell line H4IIEC3. Fado2 cells were derived from the H4IIEC3 
hepatoma cells via selection against adenosine phosphoriboyltransferase (APRT) activity and 
hypoxanthine phosphoribosyltranferase (HPRT) activity. Fg14 cells were derived from Fado2 
via dual transfecting with stable transgene constructs encoding with adenine 
phosphoribosyltranferase (APRT) and hypoxanthine-guanine phosphoribosyltranferase 
7 
(HPRT/GPT) under control of the liver specific human SERPINAJ (aka alpha-I antitrypsin) 
promoter. Transfected cells were selected by growth in media containing drugs inhibiting the de 
nova nucleotide biosynthesis and require nucleotide precursors that can be utilized by transgene 
expression: adenine-aminopetrin-thymidine (AAT) for SERPINAJ-aprt expression and 
hypoxanthine-aminopetrin-thymidine (HAT) for SERPINAJ-gpt expression. Hepatoma variant 
cell lines (Fig. I) were generated by negative selection, using toxic analogs- 2.6-diaminopurine 
(DAP) and 6-thioxanthine (6-TX). The surviving cells lack APRT and HPRT enzyme production 
as well as lack expression of the endogenous Serpinal gene (Bulla & Fournier, 1994; Bulla et al, 
2000, Bulla & Kraus, 2004). 
1. SERPINA1-Aprt 
2. SERPINA1-Gpt 
L.. 
AAT, 
Fg-14 -+ 
OAP, Fado-2 
HAT APRT+ 6TX APRT-
GPT+ GPT-
SERPINA1 + SERPINA1+ 
H11, M38 HS2, M29 
Variants 
APRT-
GPT-
SERPINA1 -
Fig.1. Derivation of the hepatoma variant cell lines. Fg14 cells contain two selectable trans-
genes - adenine-aminopterin-thymidine (AAT) and hypoxanthine-aminopetrin-thymidine (HAT) 
under the control of the liver-specific human SERPINAJ gene promoter. Selection against 
expression of these genes using 2,4-diaminopurine (DAP) and 6-thioxanthine (6TX) resulted in 
the isolation ofhepatoma variant cell lines (e.g. HS2, M38, Hl 1 and M29) which lack expression 
of several liver genes. (APRT- Adenine phosphoribosyl transferase; GPT- Guanosine 
phosphoribosyl transferase). 
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1.3. Serpinal Gene Regulation As A Model For Liver Gene Regulation 
Molecular mechanisms of transcription regulation in the liver have been studied by 
monitoring SERPINAI gene expression. Gene silencing in variants cell lines has been shown to 
be due to loss of trans-acting factors (Bulla & Fournier, 1994). All four variant cell lines used in 
the current study (Hl 1, M29, M38 and HS2) are deficient in the HNF4/HNF1 D transactivation 
pathway, resulting in loss of expression ofliver specific downstream genes including Serpinal. 
SERPINAI is a member of serine-proteinase inhibitor SERPIN super family 
(Janciauskiene et al, 2011). It is an abundantly produced circulating protease inhibitor, encoded 
by a single gene on the long arm of human chromosome 14 (Parfrey et al, 2003). In 1955, 
Schultze isolated these highly polymorphic 55 kda serum glycoproteins. They occur in the alpha-
1 globulin fraction (J anciauskiene et al, 2011) and have ability to inhibit the destructive 
neutrophil-secreted protease, elastase, and cathepsin G (Hu & Perlmutter, 2001). SERPINAI is 
principally synthesized (70-80 %) in liver cells (Janciauskiene et al, 2011) but also produced by 
pulmonary alveolar cells, macrophages, monocytes and intestinal epithelial cells (Hu & 
Perlmutter, 2001; Janciauskiene et al, 2011). The SERPINAI half-life is 3-5 days with normal 
plasma concentration ranging from 0.9-1.75 g/L. Auto-regulation of SERPINAI was observed 
when exposed to a SERPJNAl-elastase complex or elastase alone. Also, SERPINAI was shown 
to be synthesized de novo in human cancer cells (Janciauskiene et al, 2011). 
In-situ hybridization studies have shown that hepatocytes and hepatoma cell lines 
synthesize SERPINAI abundantly in cell culture (Hu & Perlmutter, 2001). SERPINAI is an ideal 
model to study the tissue specific gene expression and extinction because of the following 
characteristics: (i) liver enriched trans-acting factors HNFla and HNF4 binding site at the 
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proximal promoter of SERPINAJ has been well characterized; (ii) in hepatoma x fibroblast 
hybrids, SERPINAJ gene expression is reduced by> 1000 fold; (iii) the genes encoding HNFla 
and HNF4 are highly characterized and (iv) tissue specific expression of a gene can be obtained 
by utilization of only the 5' proximal promoter of the SERPINAJ gene (Bulla, 1999). The 
expression of the SERPINAJ gene is regulated synergistically by hepatocyte nuclear factor-1 a 
(HNFla) and HNF4 (Hu & Perlmutter, 2001). Mutations in the SERPINAJ promoter region 
prevent binding of HNFla and reduce cellular expression (Bulla & Kruas, 2004). Previous 
studies have shown that ectopic expression of trans-acting elements results in chromatin 
remodeling around the Serpinal locus, suggesting that a single transcription factor can change 
the chromatin structure of DNA and rescue the hepatic expression in variants (Rollini & 
Fournier, 1999). 
1.4. DNA Microarray Analysis 
The DNA microarray, a tool initially developed in ~1987, provides a high throughput 
data platform with which to analyze gene expression of most or all genes within a cell type or 
tissue. This technique provides whole gene expression profiling (i.e. the quantitative data of an 
expression level of thousands of genes simultaneously under different conditions). For example, 
the expression pattern of the same gene under different times and conditions can be monitored to 
elucidate the role of a given gene in genetic pathways (Hedge et al, 2000, Dorris et al, 2002). 
The process of gene clustering is based upon regulatory pathways or disease association. 
Various methods that have been used for analysis are hierarchical clustering, k-means, partitions 
around memoids (PAM a.k.a K-memoids), self-organizing maps (SOM), mixed model-based 
clustering and tight clustering (Thalamuthu et al, 2000). DNA microarrays have become highly 
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labeled probes. An image is generated and processed based upon the identifying and 
distinguishing arrayed genes against spurious signal, estimation of background signal and the 
background -subtracted hybridized intensities. The generated data is normalized by adjusting the 
differences in labeling and detection efficiencies of fluorescent labels and quantity of the starting 
RNA between the assayed samples (Hedge et al, 2000). Finally, data is analyzed and difference 
in expression level is determined based upon the cut-off value of specific threshold level 
1.5. Project Overview and Goals 
In order to elucidate the pathways for normal regular liver function in hepatoma variant 
cells, whole genome expression profiling approach was carried out in this laboratory in order to 
identify the liver specific genes that are responsible for activation or repression of gene 
expression. Four variant cell lines (M29, HS2, Hll, and M38), were tested against the parental 
hepatoma cell line Fg14. Whole genome microarray experiments were conducted using the RNA 
isolated from parental and variant cell lines. The experiment was performed in triplicate for 
reproducibility and viability, and tested by comparing against the biological replicates for each 
cell line and gene variability within the microarray. 
A total of 22,500 target genes were analyzed. Based upon the generated data, two 
criteria were implemented when comparing the gene expression between the parental hepatoma 
cell and the hepatoma variants: (i) a > 5-fold signal variability difference within replicates of 
parental against variant cell lines and (ii) at least two of the four variant cell lines tested must 
show these > 5-fold differences in expression. This led to the identification of 355 repressed 
genes, 132 of which were common in all of them. Also, 213 genes were found to be activated 
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among the variant cells lines, although only two genes were activated in all four variant cell 
lines, as shown in the Fig. 2. Further analysis was done to identify those repressed/activated 
genes that are either transcription factors or encode products that play a known role in signaling 
pathways. It was hypothesized that at least some of these genes are regulated by liver specific 
master regulators such as HNFla, HNF3~ (FOXA2), HNF4 and HNF6 (ONECUTl). From the 
pool of these genes, candidate genes were identified using two criteria: (i) a > 5 fold increase or 
decrease in expression in 2 of 4 variants compare to parental Fg14 cells and (ii) a known role in 
transcriptional activation or interaction with transcriptional activation pathways. Based upon the 
criteria, 14 repressed genes (Table 1) and 7 activated genes (Table 2) were identified as 
potentially having a capacity to contribute in maintaining the liver (hepatic) phenotype (Fig. 3). 
These preliminary data suggest that a high level of reprogramming has occurred in variant cells, 
leading to activation of few sub-sets of genes along with loss of liver-specific gene expression 
(Bulla et al, 2012). 
M38 H11 M38 H11 
HS2 M29 HS2 M29 
Fig. 2. Gene repressed and activated in hepatoma variants cells using Illumina whole genome rat 
microarray. A total of 355 genes were identified the cut-off value of > 5 fold repression 
compared to Fg14 levels, 132 genes were shared in repressed in all four variant cell lines 
whereas only 2 genes are activated by> 5 fold in all 4 variant cell lines. 
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Table.1. List of candidate genes identified from list of repressed genes. 
Fold Repression Gene name Description 
M38 HS2 Hll M29 
6.2 1.7 3.6 5.5 BHLBH2 Basic helix-loop-helix domain containing Class 2B 
12.9 15.0 14.6 13.7 CREB3L3 cAMP responsive element binding protein 3-like 3 
3.6 6.4 2.7 5.9 CREG ElA-stimulated gene (predicted) 
17.4 18.7 18.7 16.7 DPPA4 Developmental pluripotency associated 4 (LOC680293) 
(predicted) 
12.2 11.9 11.9 10.1 DPPA5 Similar to DPP A5developmental pluripotency associated 5 
(RGD1564306( (predicted) 
9.3 8.5 7.9 8.8 GAS2 Growth arrest-specific 2 (RGD1562167) (predicted) 
5.1 6.0 2.8 5.8 HHEX Hemtopoietically-expressed homeobox protein 
118.6 128.0 131.9 107.4 IGFBPl Insulin like growth factor binding protein 1 
8.3 9.6 0.1 7.4 MDK Midkine (neurite growth-promoting factor 2) 
10.7 5.3 14.9 16.9 ONECUTl One cut homeobox 1 
7.0 14.9 2.1 43.3 RNF125 Ring Finger protein 125 (predicted) 
9.4 10.3 10.6 5.3 SEC16b SEC16 homolog B (S. cerevisiae homolog) 
19.1 19.7 19.7 19.0 STRA8 Stimulated by Reinoic Acid 8 (RGD1562852) (predicted) 
3.5 9.5 1.0 21.0 TCFAP2B Transcription factor Ap-2 beta 
Table. 2. List of candidate genes identified from list of activated genes. 
Fold Activation Gene name Description 
M38 HS2 Hll M29 
21.8 15.9 19.5 6.2 TIMPl TIMP metallopeptidase inhibitor 1 
4.9 11.0 35.6 6.3 BMP7 Bone morphogenetic protein 7 
11.5 6.2 0.9 8.8 GPR177 G protein-coupled receptor 177 
1.0 15.6 0.9 27.1 PITXl Paired-like homeodomain 1 
4.6 11.0 0.8 9.0 IGFBP7 Insulin-like growth factor binding protein 7 
10.4 0.6 1.1 11.5 WIFl Wnt inhibitory factor 1 
23.2 4.1 0.9 12.8 IGFBP2 Insulin-like growth factor binding protein 2 
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Fig. 3. Candidate genes predicted to involve in regulation of liver phenotype. 
Cellular repressor of ElA stimulated gene-1 (CREGl) is one such candidate gene 
identified through microarray analysis that falls under the repressed category. Our hypothesis 
was that CREG 1 plays a role in maintaining the hepatic phenotype through activation of liver 
specific transcription factors and may therefore partially revert a non-hepatic cell type to hepatic 
phenotype. In this study, we are presuming that CREG 1 plays a vital role in regulating 
transcription factors and signaling proteins that play a significant role in the tissue-specific gene 
activation in hepatoma variant cell. This will shed light upon the role of CREG 1 on liver specific 
gene regulation. To this end, CREG 1 will be introduced into Hl 1 hepatoma variant cells and 
transfectants screened for reactivation of liver gene expression. The specific goals of this work 
include 1) Validation of tissue specific liver gene expression in hepatoma variant cell line Hl 1 
by reverse transcriptase quantitative Polymerase Chain Reaction (R T-qPCR), 2) Identification of 
liver-specific transcription factors whose expression is affected by CREG 1 3) Determination of 
the level of up-regulation or down-regulation of the downstream liver genes by CREG 1 and 4) 
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Fig.4. Flowchart showing the schematic representation of the strategy to be implemented to 
study the effects of CREGl and PITXl in hepatoma variants (Hll) and hepatoma (Fgl4) cell 
lines, respectively. 
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buffer) buffer before the suspension was added. The filter was washed with QC (wash buffer) 
buffer. The plasmid DNA was extracted with QF buffer and 0. 7 volume of iso-propanol was 
added for plasmid DNA precipitation. The tube was centrifuged at 6000 rpm for 10 min. 
Supernatant was discarded and the pellet was re-suspended in Tris - EDTA (TE) buffer (1 M Tris 
Cl; 0.5 M EDTA; pH 8) and collected in a micro-centrifuge tube. 10 M potassium acetate was 
added to one fifth of the final suspension volume along with 2.5 volumes of ethyl alcohol. The 
tube was centrifuged at maximum speed for pelleting. Supernatant was removed and the 
remaining solution was removed with a cotton swab. The pellet was resuspended in TE and 
stored at -20° C. DNA was quantified using a spectrophotometer using at a wavelength of 260 
nm. 
2.3. Restriction Digestion 
Restriction digestion was performed to verify plasmid identity. For a typical 20 µl 
reaction mixture: BamH I (5 U), EcoR I (5 U), buffer (2 µl), DNA (2 µl) and dH20 (14 µl) was 
incubated at 37° C for 1 hr. Digested fragments were separated by 1 % agarose gel 
electrophoresis, visualized by UV light and photographed with Molecular Imager Gel Doc™ 
XR+ Imaging System. 
2.4. Cell Culture 
All cells were maintained in a medium containing 1:1 Ham's Fl2/Dulbecco's modified 
Eagle's medium (FDV) containing 10% fetal bovine serum (FBS) (GIBCO BRL) and 5 µg/100 
ml penicillin-streptomycin (GIBCO) at 37° Cina humid 5% C02 water-jacketed incubator. All 
cells were derived from the parental cell line H4IIEC3, a rat tumor. The rat hepatoma variant cell 
line Hll was derived from Fg-14 cells by negative selection against Aprt (adenine 
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2.8. Quantitative-Polymerase Chain Reaction (qPCR) 
All the cDNA samples were diluted and concentration (5 ng/µl) was standardized among 
the samples. A final volume of 20 µl of reaction mixture contained 2 µl of cDNA template (5 
ng/µl), 6.75 µl of sterile nuclease free water, 10 µl of Fast SYBR® Green Master Mix (Applied 
Biosystem) and 1.25 µl of gene specific primer (0.5 µM) (IDTDNA). The applied Biosystem 
thermocycler was used to measure the expression of mRNA level. The first step was carried at 
95° C for 3 sec, followed by extension/annealing step at 5° C above melting temperature (Tm) 
for 30 sec. A final melt curve step was performed at 95° C for 15 sec down to 60° C for 60 sec 
and a final step at 95° C for 15 sec. The control for RT-qPCR contains 8.75 µl of sterile nuclease 
free water, 10 µl of Fast SYBR® Green Master Mix (Applied Biosystem) and 1.25 µl of gene 
specific primer (0.5 µM) (IDTDNA). The list of primers used for genes and their Tm is given in 
the Table 3. The cDNA quality was tested against the reference gene Gapdh. Duplicate assay 
was performed for each cell line and reaction was repeated three times. 
Raw threshold (Ct) value was averaged after the amplification for each of the cell line. 
The amplified target genes in each hepatoma and hepatoma variant were normalized to the 
respective Gapdh Ct-value, generating a delta-Ct value (LiCt). Fold differences in gene 
expression were determined with a delta delta-Ct (LiLiCt) calculation. The LiCt of the control cell 
line (Fg14) was subtracted from the hepatoma variant LiCt value, generating a LiLiCt value. Using 
a log base 2 scale, the calculated difference was placed into the LiLiCt equation: 2(LiCt (sample -
experimental) - (LiCt Control). 
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Table 3. Primers used in the quantitative Polymerase Chain Reaction (qPCR), primer sequences, 
melting temperature and annealing temperature of primers. 
Annealing 
Primer Primer Sequence Tm temperature 
(oC) {°C) 
HNFl F- 5'CCATTCTGAAAGAGCTGGAGAAC 3' 57.1 60 
R- 5' AGGTACGACTTGACCATCTTTGC 3' 55.6 
rHNF3 (4) F-5' TGGCAGAACTCCATCCGTCATTCT 3' 60.2 64 
R- 5' TCCTTCAACGCCAGTTCGTTCTCA 3' 60.5 
HNF4 F- 5' TGAGCCTGGAGGATTACATCAAC 3' 56.6 60 
R- 5' AACTGGATCTGCTCGATCATCTG 3' 56.5 
HNF6 F-5' CAGTGGCTCTAAGCACAGTAA 3' 54.5 60 
R-5' CAGTGTGGTGGAACAGATAAGA 3' 54.3 
SERPINAl F-5' CCTATACCGGGAGCTGGTCCAT 3' 60.3 64 
R-5' TTGCGAGTGTCACCCTTGCT 3' 59.5 
ALB F- 5' CATCCTGAACCGTCTGTGTG 3' 55.7 60 
R-5' TTTCCACCAAAGACCCACTA 3' 55.8 
rKNGl(l) F- 5' AACACAATTGCCGCCTTCTCACAG 3' 60.2 64 
R-5' GTGCAATGGAATGACCAAGTGCCT 3' 60.2 
rFGBl (4) F-5' AAGGAGACAAGGTGAAGGCACACT 3' 60.3 64 
R-5' AAGAACATGCCGTTGTGGATGCTC 3' 59.9 
rPCKl (2) F-5'CGCTATGCGGCCCTTCTTT3' 58.3 60 
R-5' CGTGAAAGATCTTGGGCAACT 3' 57.5 
rHHEXl (4) F-5' AGGTGCCTCTTTGGACAGTTCTCA 3' 60.1 64 
R-5' AGCCTTTATCACCCTCGATGTCCA 3' 59.8 
rWNT4 (1) F-5' CTGGACTCCCTGCCTGTCTTC 3' 59.5 60 
R-5' TCC ACTGCTGCATGCTCTTG 3' 58.1 
mPITXl (1) F-5' AACAACATCAACAACCTCACCGGC 3' 60.2 64 
R-5' ATAGCCAAACGACGAGTGCTGCTT 3' 61.2 
rGAPDH F-5' TGATTCTACCCACGGCAAGTT 3' 56.5 60 
R-5' TGATGGGTTTCCCATTGATGA 3' 54.2 
rCREGl (3) F-5' CATCAGACACCCTGAGATGAAA 3' 54.4 60 
R-5' GGTCCACCAAAGTAGTCCAAA 3' 54.8 
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Chapter 3 
Results 
In order to determine the hierarchy of signaling pathways responsible for the loss of liver 
cell function, hepatoma variant cell lines, derived from parent hepatoma cell line Fg14 without 
the use of any mutagens, were used. Variants were selected based upon their inability to activate 
an introduced SERPINAJ-Aprt transgene in Fg14 cells, with the :frequency of generation of 
variant cell lines shown to be as low as 10-6 (Bulla et al, 2012). These dedifferentiated cells, in 
which the hepatic phenotype was found to be repressed, were found to have defects in expression 
of trans-acting factors and failed to express the transgene under control of the SERPINAJ 
promoter as well as the chromosomal Serpinal gene. These variant cell lines proved to be useful 
in identifying defects in regulatory pathways. Specifically, it was found that the variant cell lines 
fail to express hepatocyte nuclear factors HNFlA and HNF4 (Bulla et al, 1994), two well-
characterized transcription factors known to play important roles in liver function and also binds 
to activate the Serpinal promoter. Thus, these cells fail to express both liver enriched 
transcription factors and downstream liver-specific genes. 
3.1. Part A. CREGl As A Candidate For Liver Gene Activation 
3.1.1. Stable Transfection And Expression Of CREGl Clones 
Cellular repressor of ElA-stimulated gene-1 (CREGl) was identified as a putative 
candidate gene, predicted to potentially play a role in activation of liver specific genes and 
transcription factors, based upon RatRef-12vl Expression Bead Chips (Illumina, Inc., San Diego, 
CA) whole genome microarrays. Microarray data showed that CREG 1 expression is repressed 3-
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also unaffected, as was Wnt4. The liver marker gene Kngl showed variable results among the 
two clones tested. The most dramatic result found was a 10-fold decrease in SERPINAl 
expression in clone Fg14-PITX1-C4, although the effect was not observed in clone Fg14-PITX1-
C2 (Fig. 14). PEPCK expression was consistently repressed 4-fold in the clones tested. 
Table 4. Expression levels of candidate gene by microarray analysis. Raw fluorescent 
values are shown for FG 14 and RA Tl cells. Ratios of gene expression of the variant cells 
compared to the parental Fgl4 cells are also shown. 
Gene RATl Fg14 RAT1/Fg14 Fgl4/M38 Fgl4/HS2 Fgl4/Hll Fg14/M29 
CREGl 4885 2791 2 
BMP7 4408 214 21 
PITXl 80 109 
3 7 
0.20 2 
1 
6 
0.08 
0.05 
6 
0.15 
0.03 
Table 5. Expression levels of transcription factors in hepatoma and hepatoma 
variant cell lines as determined by microarray data. 
Transcription Average values Fold Ex_Qression 
factors Fg14 Hll M38 Hll HS2 M29 
Cebpa 250.0 100.7 2.1 2.5 1.5 2.1 
HNF3 (FoxA2) 3417.9 5632.0 0.6 0.6 1.1 1.1 
HNFla 455.2 107.7 3.4 4.2 4.5 4.2 
HNF4 247.0 88.6 2.9 2.8 2.9 2.7 
HNF6 (Onecutl) 2011.9 134.6 10.7 14.9 5.3 16.9 
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Fig. 5. True Mouse Clone Vector pCMV6-Kan/Neo. The CMV promoter and a Kozak 
consensus sequence drive protein expression in mammalian cells. An antibiotic selection cassette 
(Kanrl Neor) confers resistance to kanamycin in E. coli and neomycin analogs (G418) in 
mammalian cells. The T7 promoter upstream of the ORF allows protein expression in cell-free 
system. Each clone contains a fully verified insert sequence 
Sample 
Control (H 11) 
Clones 
Pool 
Table 6. Hll-CREGl transfectants 
#of Clones 
0 
17 
5 
Analyzed 
NIA 
4 
3 
Over-Expressed 
NIA 
2 
1 
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Fig. 6. Expression of CREG 1 in transfected hepatoma variant H 11 cells. CREG 1 is 
overexpressed in individual clones (H 11-CREG l-C7, H 11-CREG l-C9) and pooled clones (H 11-
CREG 1-P3) as detected by qPCR, compared with Fgl4 expression levels. All values are 
normalized for RNA using Gapdh expression values for each cell line. Data are shown as mean± 
SEM, n=3, * p < 0.05. All experiments were repeated at least 3 times, with duplicate reactions 
set for each trial. 
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Fig. 7. CREGl overexpression effects in transfected Hl 1 cells. CREGl overexpression resulted 
in modest activation or repression of liver-specific transcription factors. Negative fold values 
indicate repression, and positive fold values indicate activation. All values are normalized for 
RNA levels using Gapdh expression values for each specific cell lines. All samples were 
measured in triplicate by qRT-PCR reactions. Data are shown as mean± SEM, n=3, * p < 0.05. 
All experiments were repeated at least 3 times, with duplicate reactions set for each trial. 
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Fig. 9. Downstream genes required for cellular maintenance, proliferation and differentiation 
were tested in the Hl 1-CREGl cells. ALB and PITXl were mildly activated. Other liver-
specific genes, including WNT4 and PCKl, were repressed. All values are normalized for RNA 
quality using Gapdh expression values for each specific cell lines. All samples were measured in 
triplicate by qRT-PCR reactions. Data are shown as mean ± SEM, n=3, * p < 0.05. All 
experiments were repeated at least 3 times, with duplicate reactions set for each trial. 
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Fig. 10. Downstream gene SERPINAl was strongly activated. It is a liver phenotypic biomarker. 
All values are normalized for RNA quality using Gapdh expression values for each specific cell 
lines. Data are shown as mean± SEM, n=3, * p < 0.05. All experiments were repeated at least 3 
times, with duplicate reactions set for each trial. 
36 
Sample 
Control (Fg14) 
Clones 
Pool 
Table 7. Fg14-PITX1 transfectants 
#of Clones Analyzed 
0 NIA 
7 7 
0 NIA 
Expressed 
NIA 
2 
NIA 
Fig. 11. Expression of PITXl in transfected Fg14 hepatoma cells. (A) Two of the seven clones 
examined overexpressed the Fg14-PITX1-C2 and Fg14-PITX1-C4 gene as detected by qPCR, 
compared with H 11 expression level. All values are normalized for RNA quality using Gapdh 
expression values for each specific cell lines. All samples were measured in triplicate by qR T-
PCR reactions. Data are shown as mean± SEM, n=3, * p < 0.05. All experiments were repeated 
at least 3 times, with duplicate reactions set for each trial. 
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48 KDa 
PITX1 40Kda 
fl-actin 
Fig. 12. Western blot analysis of PITXl. PITXl protein is strongly expressed in transfected Fg14-
PITX1clone-2 cells in comparison with Fg14 cells. The P-actin signal is used to control for protein 
loading. 
38 
1 
are 
samples were un.•u.c,..u 
as mean± SEM, n=3, * p < 0.05. All experiments were 
3 times, with duplicate reactions set for each trial. 
pos1t1ve fold values activation. 
quality using Gapdh expression values for each cell lines. All samples were measured 
triplicate by qRT-PCR reactions. Data are shown as mean ± SD, , * p < 0.05. All 
experiments were repeated at least 3 times, with duplicate reactions set for each trial. 
Chapter 4 
Discussion 
Mammalian gene silencing is an epigenetic phenomenon that is often efficiently 
maintained in cell hybrids. Likewise, hepatoma variants, derived from rat liver tumor cells, have 
been shown to stably silence expression of hundreds of liver specific genes (Bulla et al, 2012). 
The degree of gene silencing depends upon the silencing of tissue specific genes transcription 
factors (TFs). Several studies have demonstrated that the transcriptional regulation is controlled 
by the TFs. In the current study, cell specific TFs and genes that encode proteins involved in cell 
signaling, activated or repressed in cell systems, were identified using whole genome microarray 
analysis. Two of these candidate genes - CREGl (repressed) and PITXl (activated) were 
identified as candidate genes in at-least two out of the four hepatoma variant cells (M29, HS2, 
Hll, M38) via microarray analysis comparing expression levels to those of the parental Fg14 
cells (Bulla et al, 2010). 
4.1. Part A. CREGl As A Candidate For Liver Gene Activation 
Dedifferentiated hepatoma variant cell line H11, previously shown to be defective in 
expression of Hnfl and Hnf4 along with other downstream genes (Bulla et al, 2010), were used 
for this study. The epigenetic phenomenon of gene silencing is well characterized in the variant 
cell lines but the underlying pathways have yet to be elucidated. In this study, stable introduction 
of a CREG 1 expression plasmid into the H 11 cells results in activation of silenced transcription 
factors as well as specific downstream liver-specific genes. 
CREG 1 was first discovered while screening a cDNA library of Drosophila (fruit fly, a 
model organism) for proteins that interact with the transcription factors (Han et al, 2011). It is a 
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1. Introduction 
A progressive advancement in genomics has led to development of number of strategies 
from exploiting bacterial plasmids to retroviral to lentiviral-derived construct for gene delivery 
mechanism (Sutherland et al, 2011). But delivery of multiple genes either for therapeutic 
purpose or study of co-translational events within a cell is difficult (such as coordinately co-
expressing target genes and reporter/marker gene for tracking expression of transgenes). Several 
methods such as differential splicing, multiple promoters, gene fusions, translation reinitiation 
and internal ribosomal entry sites (IRES) (Felipe, 2004) have been exploited to generate stable 
cell lines. Internal ribosomal entry sites (IRES) are still the first choice for polycistronic 
expression. However, Sutherland et al, 2011, developed a pAc5-STABLE vector based on viral 
"2A like" sequence also known as CHYSEL (cis- acting hydrolase element) peptides to achiev 
this purpose. 
CHYSEL or 2A like sequence was first identified in aphthovirus foot and mouth disease 
virus (FMDV) and has been extensively studied. These viruses, single or double stranded RNA, 
have an 18 amino acid sequence capable of separating itself from the co-translated protein 
sequence (Doronina et al, 2008). These sequences are encoded by the short upstream ORF that 
interacts with the ribosomal exit tunnel to regulate stop codon independent termination of 
translational. They are consist of a C-terminus "-Dl2(V/I)ExNPGP19-" motif that have ability to 
recode the translational process after pausing a ribosome. Separation occurs within a polypeptide 
sequence between the Asp-Val/Ile-Glu-x-Asn-Pro-Gly(2A) and Pro(2B) amino-acids where ProC2Bl 
and is the essential portion of the active form of 2A and a first amino acid of the downstream 
protein. Due to their ability to regulate autonomously and to mediate recoding, they are also 
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known as "Stop Go" or "Stop Carry On" peptides (Sharma et al, 2011). They have been widely 
used in co-translation of multiple proteins. 
2A like or T2A (Thosea asigna derived sequence for insect cells) have been widely used 
for stable transfection of transgenes to achieve high level and coordinate stable expression of 
multiple proteins of interest (Sutherland et al, 2011). Ma et al, 1995 generated functional 
antibodies by co-expressing four different polypeptides. In order to obtain similar constitutive 
expression, Sutherland et al, 2011, used the vector pAc5.1 with the Drosophila Actin5c promoter 
as a backbone for pAc5-STABLE vectors targeting to transfecting insect cells. The control 
vector is GFP tagged (Fig.IA) whereas to generate pAc5-STABLE1-Neo (Fig.lB), T2A peptide 
was cloned between the GFP and NeoR genes. NeoR is a selectable marker to generate stable 
clones expressing the protein of interest. The pAc5-S TABLE2-N eo (Fig.1 C) contains two sites 
for expressing protein of interest with FLAG epitope tagged with mCherry fluorescent protein 
separated from GFP by another T2A peptide sequence. The flexibility to replace either the 
reporter marker or selectable marker allows one to generate a single chain of poly-cistronic 
peptide and/or with N- or C- terminal having a reporter marker (Sutherland et al, 2011). Thus, 
this technique can be exploited in generation of recombinant proteins, biomedicine, 
biotechnology and studying biochemical and signal transduction pathways. 
In this study, pAc5-STABLE2-Neo vector construct was generated to study the effect of two 
proteins via co-translation of CRGEl and HNFla in a hepatoma variant cell line Hl 1. CREGl is 
a liver specific candidate gene identified by CREG 1 whole genome microarray analysis of rat 
liver. It is a secretory glycoprotein highly expressed in vascular smooth muscles cells (VSMC) 
(Han et al, 2011) and a putative master regulator in liver (Bulla et al, 2012). Our study has 
shown that it highly regulates the SERPINAl gene, liver specific biomarker as well as the liver-
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2. Materials and Methods 
2.1. Primer Design 
The F ASTA sequence of the target gene was obtained either from the PubMed or from 
an online 
analyzer provided by San Diego Supercomputer Center, University of California, San Diego. Six 
frame analysis was performed to select the correct reading frame. Primer analyzer software 
available online from IDTDNA © was used to calculate 
melting temperature (Tm), dimer formation, hair pms formations and hetero dimers. The 
OligoAnalyzer tool was selected from a dropdown menu labeled tools. Sequence was selected 
form one of the frames and a minimum of 17 bp was entered and analyzed. The Tm of both 
primer should be more or less similar. After confirmation of primers obtained from IDTDNA, 
the Tm was was calculated via=~~=======~.:.:.. (available online at New England 
Biolab under Tools & Resources dropdown menu). 
2.2. Polymerase Chain Reaction (PCR) 
HNFl and CREGl both genes were amplified via PCR. All the primers were designed 
and ordered from IDTDNA ©. A reaction mix of 50µ1 was prepared by adding 10µ1 of Q5 
reaction buffer (5X), 1 µ1 of dNTP (10 mM), 1 µl of primer (5 µM), 1 µl of template DNA (10 
ng/µl), 0.5 µl of Q5 high-fidelity DNA polymerase (5 U/µl) into final volume maintained by 
adding sterile water. After reaction mixture was prepared, a 30 cycle PCR program was set on a 
BioRad Thermocycler with an initial denaturation at 98° C for 30 sec, annealing temperature at 
55-58° C for 30 sec, extension at 72° C for 30 sec. A final extension for unpaired bases and 
reaction to complete was set at 72° C for 120 sec and the reaction was held at 4° C. 
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2.3 Plasmid Isolation 
Bacterial cultures were grown overnight in a LB media containing 50 µg/ml ampicillin at 
3 7° C in a shaking incubator at 225 rpm. Plasmid was isolated using a SNAP Mini prep Kit 
(Invitrogen®). The culture was transferred into 1.5 ml microfuge tubes and centrifuged at 14,000 
g for 10 min and the supernatant was discarded. The pellet was resuspended in 150 µl of 
resuspension buffer and mixed by inverting the tube 5-6 times. 150 µl of lysis buffer was added 
and mixed by inverting. The tube was then incubated at room temperature for 3 min followed by 
150 µl of precipitation buffer was added, mixed, and centrifuged at 14,000 g for 5 min. The 
supernatant was transferred into microfuge tube and pellet was discarded. 600 µl of binding 
buffer was added, mixed thoroughly and entire mixture was transferred into a column in a 
microfuge tube. The column was centrifuged at 3,000 g for 1 min and flow-through was 
discarded. 500 µl of wash buffer was applied in the column and centrifuged at 3,000 g for 1 min. 
Flow-through was discarded. 900 µl of wash buffer was added in the column for final wash. The 
column was centrifuged at 3,000 g for 1 min and flow-through was discarded. The column was 
dried by centrifuging at 14,000 g for 1 min., then transferred to a sterile microfuge tube. 60 µl of 
TE/H20 was added and the sample incubated at room temperature for 3 min. Plasmid was eluted 
by centrifuging the column at 14,000 g for 1 min. The extracted plasmid was quantified and 
stored at -20° C. 
2.4. Vector/Insert Digestion for Cloning 
The quantified pAc5-STABLE2-Neo plasmid was digested for cloning. For digestion of 
the plasmid, 10 µl (2.5 µg) of vector, 10 µl of cutsmart buffer, 2.5 µl of restriction enzyme 1 and 
2.5 µl of restriction enzyme 2 and 75 µl of DNase/RNase free water was added in a PCR tube. 
Then, the reaction mixture tube was incubated at 37° Cina Biorad Thermocycler for 1 hr. Four 
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different enzymes were used; HF-EcoRI (10 U/µ1), HF-Kpnl (10 U/µl), HF-EcoRV (10 U/µl) 
and Xbal (10 U/µl) for restriction digestion. During restriction digestion, the vector was 
incubated in XbaI for 2 hrs while only for 1 hr with the other high-fidelity enzymes. All 
enzymes except Kpnl could be deactivated by increasing the temperature to 60° C, but the HF-
Kpnl digested vector was purified by using the plasmid purification kit. The digested vector was 
finally treated with 0.25 µ1/100µ1 of CIP (calf-intestine phosphatase) for 1 hr and then purified 
using a plasmid purification kit. 
2.5. Plasmid Vector Purification/PCR Reaction Clean-up 
Restriction digested plasmid DNA was amplified and run in a 1 % agarose gel in TAE 
buffer for 1 hr at 90 V. The final product of extraction and amplified product was cleaned-up 
using NucleoSpin® Gel & PCR Clean-up purification kit. According to protocol, if it is a gel 
purified product, it should be preheated at 60° C till agarose melts before 2X volume of NTI 
buffer was added to the final product. If not 2X volume of NTI buffer was added directly. The 
mixture was then added in a purification column and centrifuged at 11,000 g for 30 sec. Flow 
through was discarded and 700 µl ofNT3 buffer was added in the column, centrifuged at 11,000 
g for 30 sec and repeated twice if needed. Again, flow-through was discarded and the column 
was dried by centrifuging at 11,000 g for 1-2 min. The column purified plasmid/PCR product 
was eluted by adding 25 µl of NE buffer, incubated at room temperature for 1 min and 
centrifuged at 11,000 g for 1 min. The final product was quantified and stored at -20° C. 
2.6. Ligation 
The purified RE digested T2A vector and insert were quantified for ligation. In a PCR 
tube, 2 µl of T4 DNA ligase buffer (lOX), and 0.5 µl of Ligase (10 U/µ1) was added along with a 
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DNA vector: insert ratio of 1 :3 having a concentration of 2.5 µg/µl each. The \ final volume of 
10 µl was maintained by adding sterile water. For ligation reactions at the first site with mCherry 
FLAG, the reaction mixture was incubated at 37° C for 1 hr. For ligation to the second site with 
the GFP tag, reactions were incubated at room temperature for 2 hrs. After completion of the 
reaction, these cells were transformed in to competent E.coli cells. 
2.7. Transformation 
Competent E.coli cells were thawed on ice and 2 µl of ligated DNA was added in 
competent cells vial and incubated on ice for 30 min. Cells were heat-shocked using a water-bath 
maintained at 42° C for 30 sec. and the vial was then removed and placed on ice for 5 min. 250 
µl of SOC media was added in the vial and incubated on a shaking incubator (225 rpm) at 37° C 
for 1 hr. A pre-incubated LB agar plates containing 50 µg/µl of ampicillin was seeded with 50 µl 
of transformed cells and spread through-out the plate using glass hockey sticks. Plates were 
incubated overnight and at 37° C and checked for transformed bacterial colonies. Colonies were 
picked into LB broth containing ampicillin, incubated overnight on a shaking incubator and 
plasmid was extracted as described under the topic "Plasmid isolation". 
2.8. Transfection 
Semi-confluent cell plates were used for the transfection of candidate genes. FDV (0.5 
ml) media without penicillin and streptomycin was added to a microfuge tube. DNA (2 µl) along 
with 5 µl Lipofectamine Plus reagent (Invitrogen, Inc) was added and mixed gently for 5 min at 
room temperature. Then, 5 µl of of Lipofectamine LTX reagent was added and mixed gently by 
pipetting and incubated for 30 min at room temperature. 
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3. Results 
Hepatocyte nuclear factor-1 (HNFl) and cellular repressor of ElA stimulated gene -1 
(CREGl) was inserted in T2A plasmid pAc5-STABLE2-Nea. The gene inserts were verified by 
gel electrophoresis as shown in the Fig. 2 .. Transfection of the hepatoma variant Hl l cells was 
performed to check the compatibility of the insect actin promoter in mammalian cells. Neither of 
the reporter genes - mCherry or GFP - were expressed as determined by fluorescence 
microscopy. 
1 2 3 
Fig.2. Gel electrophoresis of pAc5-STABLE2-Nea construct with different target genes. Lane 1 
is a standard lkb ladder. Lane 2 is pAc5-STABLE2-Nea with HNFl gene inserted at the first 
site. Lane 3, pAc5-STABLE2-Nea with both HNFl and CREGl gene inserted. 
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4. Discussion 
In this study, pAc5-STABLE2-Nea with two inserted target genes, Hnfla and Cregl was 
constructed under control of the insect promotercpAc5. When transfected into mammalian Hl 1 
cells, no cellular expression of the fluorescent marker genes was detected. This might be due to 
actin used to construct the T2A vector by Sutherland is of insect origin rather than mammalian, 
although actin is highly conserved gene. To overcome this non-expressive problem, the actin 
promoter should be replaced with widely used mammalian promoter such as the cytomegalovirus 
(CMV) promoter via a PCR-based cloning process. 
Signal transduction is a meshwork of various cross-talk between different pathways 
which can regulate cellular proliferation, differentiation and maintenance. Some of these 
pathways have specific transcriptional regulators such as HNFl, a liver enriched transcriptional 
factor which regulates the transcriptional control of the liver specific downstream genes (Odom 
et al, 2004). In contrast, CREGl is a secretory glycoprotein, expressed ubiquitously in 
differentiated tissues rather than being restricted to single type of cell (Han et al, 2011). A study 
by Veal et al, 1998 reveals that it regulates transcription via the RNA polymerase II (i.e. it is a 
transcription factor binding complex). CREG 1 can also antagonize the transcriptional activation 
and cellular transformation by the adenovirus ElA protein which requires the interaction with 
insulin like growth factor receptor-2 (IGF2R). The ability of CREG 1 to bind the general 
transcriptional factor TBP and tumor suppressor, Rb is also verified via gene card analysis 
\~~'.!...X::.~~~~~~'!J:f;J (Veal et al, 2000). Transfection of both the genes via a T2A vector 
construct in the hepatoma variant cell Hl 1 will help to elucidate crosstalk between these two 
different proteins and the genes they regulate. 
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